Evidence map›Paper›PMID 35817490›Full record

ArticleBMJ case reports2022

Sodium-glucose cotransporter 2 inhibitor-associated severe epididymo-orchitis.

Rahul Mishra, Ghada Elshimy, Lakshmi Kannan, Rishi Raj

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Rahul MishraResearch Fellow, Hematology and Oncology, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
Ghada ElshimyEndocrinology, Augusta University Medical College of Georgia, Augusta, Georgia, USA.ORCID http://orcid.org/0000-0002-6372-9099
Lakshmi KannanNephrology, Pikeville Medical Center, Pikeville, Kentucky, USA.
Rishi RajEndocrinology, Diabetes, and Metabolism, Pikeville Medical Center, Pikeville, Kentucky, USA rishiraj91215@gmail.com.ORCID http://orcid.org/0000-0002-4151-3246
Augusta University · USCleveland Clinic · USPikeville Medical Center · USUniversity of Pikeville · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A man in his late 50s, with uncontrolled type 2 diabetes mellitus (T2DM) and morbid obesity, presented to the hospital with complicated epididymo-orchitis. The onset of symptoms (scrotal pain, erythema and swelling) occurred after the use of empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, for 2 months. His baseline antidiabetic medications were insulin, glipizide and metformin. Initially, he had failed treatment of epididymo-orchitis with oral levofloxacin for 3 weeks, followed by 2 weeks of doxycycline therapy. At the presentation to the hospital, an ultrasound of the scrotum revealed scrotal and right testicular abscess. The patient underwent right inguinal orchiectomy. Postoperatively, pus culture was positive for

Indexed as

Diabetes Mellitus, Type 2EpididymitisOrchitisGlucoseHumansMaleSodiumGlucoseSodiumDiabetesEndocrine systemInfectionsUrinary and genital tract disordersUrinary tract infections

Identifiers

PMID35817490
PMCPMC9274511
OpenAlexW4285009852

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.